Status of work in November
In November, AOTMiT begins work on orders from the Minister of Health:
- Keytruda (pembrolizumab) for the treatment of patients with lung cancer and pleural mesothelioma
- Krazati (adagrasib) for the treatment of lung cancer and pleural mesothelioma
- Jemperli (dostarlimab) for the treatment of patients with endometrial cancer
- Diaflix (dapagliflozin) for the treatment of type 2 diabetes
The listed order is available on the AOTMiT Public Information Bulletin.